Tris Pharma Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
500
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$5.27M
Tris Pharma General Information
Description
Manufacturer of medicines specializing in the development of pharmaceutical science and technology-based products. The company focuses on the commercialization of both branded products and specialty generic products and is involved in the delivery of sustained release in the liquid, chewable, orally-disintegrating tablet, and strip dosage forms.
Contact Information
Website
www.trispharma.comCorporate Office
- 2031 US Highway 130
- Monmouth Junction, NJ 08852
- United States
Corporate Office
- 2031 US Highway 130
- Monmouth Junction, NJ 08852
- United States
Tris Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Debt - PPP | 13-Apr-2020 | $5.27M | Completed | Generating Revenue | ||
| 2. Debt Refinancing | 04-Oct-2018 | Completed | Generating Revenue | |||
| 1. Debt - General | Completed | Generating Revenue |
Tris Pharma Comparisons
Industry
Financing
Details
Tris Pharma Competitors (44)
One of Tris Pharma’s 44 competitors is Alkermes, a Formerly VC-backed company based in Dublin, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alkermes | Formerly VC-backed | Dublin, Ireland | ||||
| CMP Pharma | Formerly PE-Backed | Farmville, NC | ||||
| Alvogen Group | Formerly PE-Backed | Morristown, NJ | ||||
| Krystal Biotech | Formerly VC-backed | Pittsburgh, PA | ||||
| Lannett | Corporate Backed or Acquired | Trevose, PA |
Tris Pharma Patents
Tris Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024425071-A1 | Liquid clonidine extended release composition | Pending | 02-Feb-2024 | ||
| WO-2025165367-A1 | Liquid clonidine extended release composition | Pending | 02-Feb-2024 | ||
| US-20250025432-A1 | Methods for improving driving behavior | Pending | 27-Feb-2023 | ||
| EP-4658242-A1 | Low sodium oxybate once nightly composition | Pending | 03-Feb-2023 | ||
| US-12533314-B2 | Low sodium oxybate once nightly composition | Active | 03-Feb-2023 | A61K9/0095 |
Tris Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tris Pharma Acquisitions (2)
Tris Pharma’s most recent deal was a Merger/Acquisition with Park Therapeutics. The deal was made on 29-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Park Therapeutics | 29-Apr-2021 | Merger/Acquisition | Drug Discovery | ||
| NextWave Pharmaceuticals | 25-Sep-2018 | Merger/Acquisition | Drug Discovery |
Tris Pharma FAQs
-
When was Tris Pharma founded?
Tris Pharma was founded in 2000.
-
Where is Tris Pharma headquartered?
Tris Pharma is headquartered in Monmouth Junction, NJ.
-
What is the size of Tris Pharma?
Tris Pharma has 500 total employees.
-
What industry is Tris Pharma in?
Tris Pharma’s primary industry is Drug Discovery.
-
Is Tris Pharma a private or public company?
Tris Pharma is a Private company.
-
What is Tris Pharma’s current revenue?
The current revenue for Tris Pharma is .
-
Who are Tris Pharma’s competitors?
Alkermes, CMP Pharma, Alvogen Group, Krystal Biotech, and Lannett are some of the 44 competitors of Tris Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
